Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T13:41:19.647Z.
Consensus retrieved: 2026-10-06T09:26:34.804Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T13:41:19.647Z.
Quote observation: 2026-10-06T13:40:05.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b8a0cb47064437e8b9c77c3ec53eeb060705b9d611480c07f1c1fa4a72564033
Forward PE Ratio (N/A) = Dated Quote Price ($6.18) / Consensus Forward EPS ($-121.50)
FORWARD PE RATIO
N/A
bioAffinity Technologies, Inc.
Market Cap
$2.59M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.59M | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.68M | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.74M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $2.38M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.12M | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.35M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $6.18, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-121.50 | $-121.50 – $-121.50 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
